Latest filing published 02 Jan 2020 for F-star Therapeutics, Inc., €45k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -14.8%Entry US$1.35 · Close at T+365 US$1.15
- +23.7%Entry US$0.80 · Close at T+365 US$0.99
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kurt M. Eichler: trading record in brief
Filings by Kurt M. Eichler span 2 companies, the busiest being F-star Therapeutics, Inc. and Mimedx Group, Inc. We count 36 filings; the first trade dates from 20 August 2009 and the latest from 30 December 2019.
In open-market terms, that means 12 purchases worth €1.5M on one side and 1 sale worth €45k on the other. Netting one side against the other leaves €1.5M of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 23 share grants. In 2020 alone, the filings show no purchases and 1 sale.
The median purchase comes to €13k. 8 out of 10 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The record was last updated on 2 January 2020 with an open-market sale (€45k) in F-star Therapeutics, Inc. The last purchase on record was published on 27 June 2017, which is 3,422 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kurt M. Eichler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 40,000 shares@ US$1.26100.0% of flowCommon StockSEC:0001209191-20-000391:0
- 1,198 shares0Common StockSEC:0001209191-19-000998:0
- 978 shares0Common StockSEC:0001209191-18-053071:0
- 957 shares0Common StockSEC:0001209191-18-040544:0
- 773 shares0Common StockSEC:0001209191-18-022886:0
- 979 shares0Common StockSEC:0001209191-18-000823:0
- 919 shares0Common StockSEC:0001209191-17-054988:0
- 936 shares0Common StockSEC:0001209191-17-043261:0
- 76,923 shares@ US$13.0040.1% of flowCommon StockSEC:0001209191-17-041977:0Canonical exit: 25 Sept 2017 (T+90)
- 1,200 shares@ US$8.760.5% of flowCommon StockSEC:0001209191-17-014725:0Canonical exit: 24 May 2017 (T+90)
- 3,520 shares0Common StockSEC:0001209191-17-002703:0
- 64,100 shares@ US$9.1225.0% of flowCommon StockSEC:0000899243-16-034291:0
- 7,000 shares@ US$8.692.5% of flowCommon StockSEC:0001209191-16-149404:0Canonical exit: 7 Feb 2017 (T+90)
- 650 shares@ US$12.500.3% of flowCommon StockSEC:0001209191-16-142151:0Canonical exit: 15 Dec 2016 (T+90)
- 1,346 shares@ US$12.500.7% of flowCommon StockSEC:0001209191-16-142151:1Canonical exit: 18 Dec 2016 (T+90)
- 514 shares@ US$12.500.3% of flowCommon StockSEC:0001209191-16-141569:0Canonical exit: 13 Dec 2016 (T+90)
- 490 shares@ US$12.500.2% of flowCommon StockSEC:0001209191-16-141381:0Canonical exit: 12 Dec 2016 (T+90)
- 3,000 shares@ US$10.731.3% of flowCommon stockSEC:0001209191-16-138554:0Canonical exit: 21 Nov 2016 (T+90)
- 1,000 shares@ US$9.790.4% of flowCommon StockSEC:0001209191-16-135748:0Canonical exit: 2 Nov 2016 (T+90)
- 41,666 shares@ US$12.0019.9% of flowCommon StockSEC:0000899243-16-019806:0Canonical exit: 9 Aug 2016 (T+90)
- 9,375 shares@ US$8.003.0% of flowCommon StockSEC:0000899243-16-019806:1
- 10,416 shares@ US$9.003.7% of flowCommon StockSEC:0000899243-16-019806:5
- 25,247 shares@ US$1.50Common StockSEC:0001140361-12-034294:0
- 12,497 shares@ US$0.01Common StockSEC:0001140361-12-018172:0
- 51,086 shares@ US$1.10Common StockSEC:0001140361-12-004626:0
25 of 28 declarations
